PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
26-Feb-2026 Breast Imaging Industry Witnesses Breakthrough Expansion Amid Rising Early Detection Demand Market Reports
26-Feb-2026 Prostate Cancer Competitive Landscape Analysis 2026: Clinical Trial Trends, Novel Therapies, Regulatory Milestones, and Future Outlook | DelveInsight Medi-Tech Insights
26-Feb-2026 Women’s Health Therapeutics Market Set for Robust Growth Amid Rising Focus on Gender-Specific Healthcare VMR
26-Feb-2026 Everest Medicines Shareholders Pass Resolutions Including Commercialization Service Agreement at EGM Everest Medicines Limited
26-Feb-2026 AlzeCure Publishes its Year-End Report for January - December 2025 ACCESS Newswire
26-Feb-2026 Vicore Pharma to Present at Upcoming Investor Conferences ACCESS Newswire
26-Feb-2026 BioInvent International AB: Year-End Report January 1 - December 31, 2025 ACCESS Newswire
26-Feb-2026 Invitation to Presentation of BioInvent's Year-End Report 2025 ACCESS Newswire
26-Feb-2026 FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs from Merck Animal Health – The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Control of Pruritus Associated with Allergic Dermatitis Businesswire
26-Feb-2026 Thermo Fisher Scientific Increases Quarterly Dividend Businesswire
26-Feb-2026 ON24 Announces Fourth Quarter and Full Year 2025 Financial Results Businesswire
26-Feb-2026 GoodRx Reports Fourth Quarter and Full Year 2025 Results Businesswire
26-Feb-2026 Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results Businesswire
26-Feb-2026 AdaptHealth Corp. to Participate in Upcoming Investor Conferences Businesswire
26-Feb-2026 Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Developments Businesswire
26-Feb-2026 Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update Businesswire
26-Feb-2026 Innoviva Reports Fourth Quarter and Full Year 2025 Financial Results; Highlights Recent Company Progress Businesswire
26-Feb-2026 TriSalus Life Sciences to Host Fourth Quarter 2025 Financial Results Conference Call Businesswire
25-Feb-2026 Portal Innovations Taps Seasoned Executive to Lead Its Newest Powered by Portal Site at the New Jersey Innovation Hub Businesswire
25-Feb-2026 Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy Businesswire